Skip to content

Occurrence of psilocybin and psilocin in Psilocybe pseudobullacea (Petch) Pegler from the Venezuelan Andes

Vicente Marcano, Antonio Morales Méndez, Francesco Castellano, Franklin J. Salazar, L. Martínez

Journal of Ethnopharmacology July 1, 1994 DOI: 10.1016/0378-8741(94)90013-2 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Observational study Peer reviewed
Population Two Psilocybe mushroom species (P. montana and P. pseudobullacea) from the Venezuelan Andes
Topics Psilocybin
Keywords Hallucinogen
Citations 18
Key findings Psilocybin and psilocin were found in P. pseudobullacea but not in P. montana.

Abstract

Using thin-layer chromatographic and spectroscopic (UV) methods two Psilocybe species from the Venezuelan Andes were analysed for the hallucinogens psilocybin and psilocin. These species are: P. montana (Pers. ex Fr.) Kumm and P. pseudobullacea (Petch) Pegler. Both hallucinogens were found in P. pseudobullacea, while P. montana was found to be exempt of these compounds.

Comparable studies

Other observational and cohort studies on psilocybin, most cited first.

Study Year Design Participants
Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms. Patients with treatment-resistant depression 2017 Observational cohort n = 19
Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels Healthy volunteers 2019 Observational cohort n = 8
Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin Humans 2017 Observational study
Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population. USA adult respondents from the National Survey on Drug Use and Health (2008-2012) 2015 Observational cohort n = 190,000
Prediction of Psilocybin Response in Healthy Volunteers Healthy volunteers 2012 Observational cohort n = 409

Citations in the library

Explore topics